Sham-Controlled Randomized Pilot Trial on Baroreflex Activation Therapy in Resistant Hypertension.,Hypertension

当前位置： X-MOL 学术 › Hypertension › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Sham-Controlled Randomized Pilot Trial on Baroreflex Activation Therapy in Resistant Hypertension.
Hypertension ( IF 6.9 ) Pub Date : 2024-07-17 , DOI: 10.1161/hypertensionaha.124.23088
Johan R Simonsen _{1,

2,

3,

4} , Leena Vikatmaa ₅ , Pirkka Vikatmaa ₆ , Mika Laine ₇ , Hanna Granroth-Wilding ₈ , Per-Henrik Groop _{1,

2,

3,

9} , Ilkka Tikkanen _{2,

4,

10} , Daniel Gordin _{2,

4,

10,

11}

Affiliation

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Finland (J.R.S., P.-H.G.).
Department of Nephrology (J.R.S., P.-H.G., I.T., D.G.), University of Helsinki and Helsinki University Hospital, Finland.
Research Program for Clinical and Molecular Metabolism (J.R.S., P.-H.G.), Faculty of Medicine, University of Helsinki, Finland.
Minerva Foundation Institute for Medical Research, Helsinki, Finland (J.R.S., I.T., D.G.).
Department of Anesthesiology (L.V.), University of Helsinki and Helsinki University Hospital, Finland.
Department of Vascular Surgery (P.V.), University of Helsinki and Helsinki University Hospital, Finland.
Heart and Lung Center, Helsinki University and Helsinki University Central Hospital (M.L.).
Biostatistics Unit (H.G.-W.), Faculty of Medicine, University of Helsinki, Finland.
Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia (P.-H.G.).
Helsinki Hypertension of Excellence (I.T., D.G.), University of Helsinki and Helsinki University Hospital, Finland.
Joslin Diabetes Center, Harvard Medical School, Boston, MA (D.G.).